 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 December 2002 | Volume 137 Issue 11 | Pages 889-903
Many patients with cancer use complementary and alternative medical (CAM) therapies. Physicians need authoritative information on CAM therapies to responsibly advise patients who seek these interventions. This article summarizes current evidence on the efficacy and safety of selected CAM therapies that are commonly used by patients with cancer. The following major categories of interventions are covered: dietary modification and supplementation, herbal products and other biological agents, acupuncture, massage, exercise, and psychological and mind–body therapies. Two categories of evidence on efficacy are considered: possible effects on disease progression and survival and possible palliative effects. In evaluating evidence on safety, two types of risk are considered: the risk for direct adverse effects and the risk for interactions with conventional treatments. For each therapy, the current balance of evidence on efficacy and safety points to whether the therapy may be reasonably recommended, accepted (for example, dietary fat reduction in well-nourished patients with breast or prostate cancer), or discouraged (for example, high-dose vitamin A supplementation). This strategy allows the development of an approach for providing responsible, evidence-based, patient-centered advice to persons with cancer who seek CAM therapies.
Author and Article Information
From Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Canadian College of Naturopathic Medicine and University of Toronto, Toronto, Ontario, Canada; and National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland.
Grant Support: In part by grant U24 AR 43441 from the National Institutes of Health, Bethesda, Maryland; the John E. Fetzer Institute, Kalamazoo, Michigan; American Specialty Health Plans, San Diego, California; the Bernard Osher Foundation, San Francisco, California; and the Kevin Kelly Fund, Boston, Massachusetts.
Potential Financial Conflicts of Interest:Consultancies: H. Boon; Honararia: M. Smith, D.M. Eisenberg; Stock ownership or options (other than mutual funds): H. Boon, M. Smith, D.M. Eisenberg.
Requests for Single Reprints: Wendy A. Weiger, MD, PhD, Osher Institute, Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School, The Landmark Center, 2nd Floor West, Suite 22A, 401 Park Drive, Boston, MA 02215; e-mail, wendy_weiger{at}hms.harvard.edu.
Current Author Addresses: Drs. Weiger, Kaptchuk, and Eisenberg: Osher Institute, Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School, The Landmark Center, 2nd Floor West, Suite 22A, 401 Park Drive, Boston, MA 02215.
Dr. Smith: Canadian College of Naturopathic Medicine, 1255 Sheppard Avenue, East, North York, Ontario M2K 1E2, Canada.
Dr. Boon: Faculty of Pharmacy, University of Toronto, 19 Russell Street, Toronto, Ontario M5S 2S2, Canada.
Dr. Richardson: National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard #406, Bethesda, MD 20892. ACADEMIA AND CLINIC
COMPLEMENTARY AND ALTERNATIVE MEDICINE SERIES
Series Editors: David M. Eisenberg, MD, and Ted J. Kaptchuk, OMD
Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. H Hanigan, B. L dela Cruz, D. M Thompson, K. C Farmer, and P. J Medina Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation Journal of Oncology Pharmacy Practice, September 1, 2008; 14(3): 123 - 130. [Abstract] [PDF]
|
|
|
|
 |
|
 V. S. Eschiti Lesson From Comparison of CAM Use by Women With Female-Specific Cancers to Others: It's Time to Focus on Interaction Risks With CAM Therapies Integr Cancer Ther, December 1, 2007; 6(4): 313 - 344. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Chen, K. A. Power, J. Mann, A. Cheng, and L. U. Thompson Flaxseed Alone or in Combination with Tamoxifen Inhibits MCF-7 Breast Tumor Growth in Ovariectomized Athymic Mice with High Circulating Levels of Estrogen Experimental Biology and Medicine, September 1, 2007; 232(8): 1071 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Cassileth, G. E. Deng, J. E. Gomez, P. A. S. Johnstone, N. Kumar, and A. J. Vickers Complementary Therapies and Integrative Oncology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 340S - 354S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Johnston, C. Yang, K.-K. Hui, B. Xiao, X. Li, and A. Rusiewicz Acupuncture for Chemotherapy-Associated Cognitive Dysfunction: A Hypothesis-Generating Literature Review to Inform Clinical Advice Integr Cancer Ther, March 1, 2007; 6(1): 36 - 41. [Abstract] [PDF]
|
|
|
|
 |
|
 L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito Dietary supplements in patients with cancer: Risks and key concepts, part 1 Am. J. Health Syst. Pharm., February 15, 2007; 64(4): 369 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Hlubocky, M. J. Ratain, M. Wen, and C. K. Daugherty Complementary and Alternative Medicine Among Advanced Cancer Patients Enrolled on Phase I Trials: A Study of Prognosis, Quality of Life, and Preferences for Decision Making J. Clin. Oncol., February 10, 2007; 25(5): 548 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-Wahnefried, B. Grant, A. McTiernan, C. L. Rock, C. Thompson, T. Gansler, et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices CA Cancer J Clin, November 1, 2006; 56(6): 323 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hann, S. Allen, D. Ciambrone, and A. Shah Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther, September 1, 2006; 5(3): 224 - 231. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Post-White, R. Hawks, A. O'Mara, and M. J. Ott Future Directions of CAM Research in Pediatric Oncology Journal of Pediatric Oncology Nursing, September 1, 2006; 23(5): 265 - 268. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence Oncologist, July 1, 2006; 11(7): 732 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-K. Hui, E. K. Hui, and M. F. Johnston The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East-west medicine. Integr Cancer Ther, March 1, 2006; 5(1): 56 - 62. [Abstract] [PDF]
|
|
|
|
|
|
I. Bairati, F. Meyer, M. Gelinas, A. Fortin, A. Nabid, F. Brochet, J.-P. Mercier, B. Tetu, F. Harel, B. Abdous, et al. Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients J. Clin. Oncol., August 20, 2005; 23(24): 5805 - 5813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Jacobson, V. R. Grann, M. A. Gnatt, H. Hibshoosh, J. H.M. Austin, W. S. Millar, and A. I. Neugut Cancer Outcomes at the Hufeland (Complementary/Alternative Medicine) Klinik: A Best-Case Series Review Integr Cancer Ther, June 1, 2005; 4(2): 156 - 167. [Abstract] [PDF]
|
|
|
|
 |
|
 B. T. Shaikh and J. Hatcher Complementary and Alternative Medicine in Pakistan: Prospects and Limitations Evid. Based Complement. Altern. Med., June 1, 2005; 2(2): 139 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hann, F. Baker, M. Denniston, and N. Entrekin Long-term Breast Cancer Survivors' Use of Complementary Therapies: Perceived Impact on Recovery and Prevention of Recurrence Integr Cancer Ther, March 1, 2005; 4(1): 14 - 20. [Abstract] [PDF]
|
|
|
|
|
|
G. Deng and B. R. Cassileth Integrative Oncology: Complementary Therapies for Pain, Anxiety, and Mood Disturbance CA Cancer J Clin, March 1, 2005; 55(2): 109 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Rosenthal and E. Dean-Clower Integrative Medicine in Hematology/Oncology: Benefits, Ethical Considerations, and Controversies Hematology, January 1, 2005; 2005(1): 491 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Ostrander, K. C. Cheng, J. C. Wolf, and M. J. Wolfe Shark Cartilage, Cancer and the Growing Threat of Pseudoscience Cancer Res., December 1, 2004; 64(23): 8485 - 8491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ben-Arye and M. Frenkel An Approach to Teaching Physicians about Complementary Medicine in the Treatment of Cancer Integr Cancer Ther, September 1, 2004; 3(3): 208 - 213. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L de Lemos, L. John, L. Nakashima, R. K. O'Brien, and S. C. Taylor Advising Cancer Patients on Natural Health Products--A Structured Approach Ann. Pharmacother., September 1, 2004; 38(9): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Cassileth and G. Deng Complementary and Alternative Therapies for Cancer Oncologist, February 1, 2004; 9(1): 80 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Moliver Complementary and Alternative Medicine in Cancer Ann Intern Med, July 15, 2003; 139(2): 152 - 152. [Full Text] [PDF]
|
|
|
|
|
|
Correction: Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer Ann Intern Med, July 15, 2003; 139(2): 155 - 155. [Full Text] [PDF]
|
|
|
|
|
|
C. E. Piersen Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138. [Abstract] [PDF]
|
|
|
|
 |
|
 C. R. Lewis, A. de Vedia, B. Reuer, R. Schwan, and C. Tourin Integrating complementary and alternative medicine (CAM) into standard hospice and palliative care American Journal of Hospice and Palliative Medicine, May 1, 2003; 20(3): 221 - 228. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Recent Recommendations on Complementary and Alternative Medicine J Natl Cancer Inst, January 15, 2003; 95(2): 97 - 97. [Full Text]
|
|
Article
